Table 4. Analysis of CSF in TBM patients.
| CSF Analysis | Total TBM patients |
TBM patients with DST |
||
|---|---|---|---|---|
| Median (IQR) | Abnormal (%) | Median (IQR) | Abnormal (%) | |
| Opening pressure (cm H2O) | 160 (105, 200) | 94/401 (23.4) | 170 (118, 194) | 14/34 (40.0) |
| Total leukocyte count (x106/l) | 70 (10, 210) | 305/401 (76.1) | 140 (60, 310) | 31/35 (88.6) |
| Lymphocytes (×106/l) | 14 (0, 110) | 204/401 (50.9) | 57 (0, 90) | 19/35 (54.3) |
| CSF glucose (mmol/l) | 2.31 (1.54, 3.37) | 345/401 (86.0) | 2.1 (1.72, 3.49) | 26/35 (74.3) |
| CSF protein (mg/dl) | 1.31(0.53, 2.2) | 339/401 (84.5) | 1.4 (0.03, 5.06) | 32/35 (91.4) |
| CSF chlorinate (mmol/l) | 117.1 (108.9,125.2) | 263/401 (65.6) | 111.4 (109.8, 121.3) | 28/35 (80.0) |
| CSF IgG index | 0.613 (0.51,0.735) | 89/401 (22.2) | 0.7 (0.464, 0.702) | 4/23 (17.4) |
| CSF IgG synthesis rate | 14.85 (0, 49.38) | 329/401 (82.0) | 13.1 (0, 127) | 18/23 (78.3) |
*p < 0.05.
**p < 0.01.